Is a complete LON/0R02 research report available?

No complete published report is available for lon/0R02 (LON/0R02) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0R02 (LON/0R02)

London Stock Exchange: LON/0R02 · USD

$0.26

+0.01 (+2.1%)· Recorded snapshot

Market cap	3.1M
Revenue (ttm)	84.4K
Net income (ttm)	-9.3M
EPS (ttm)	-$2.84
Volume	6,100
Beta	1.13

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 84.4K
Net income (ttm): -9.3M
EPS (ttm): -$2.84
Market cap: 3.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-09 02:00 UTC

All LON/0R02 indicators

Market & fundamental data

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	15
Employees Change	0%
Employees Change Percent	0
Enterprise value	$2.1M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US68620A3023
Last refreshed	2026-09-09
Market cap	$3.1M
Price	$0.26
Price currency	USD
Rev Per Employee	5,627.6x
Sector	Healthcare
Sector PE	21.55
Sector PE Fwd	13.76
Sic	2836
Symbol	lon/0R02
Website	https://vivosim.ai

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-304.34%
EV/Sales	24.8x
FCF yield	-249.7%
P/B ratio	-1.73x
P/S ratio	36.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-3.1M
Gross Profit Growth Q	-83.33%
Net Income	$-9.3M
Net Income Growth Quarters	8%
Net Income Growth Years	2%
Pretax Margin	-11,011.66%
Profit Per Employee	$-619,943
ROA	-89.5
Roa5y	-54.39
ROCE	-579.9
ROE	-343.1
Roe5y	-118.8
ROIC	-170

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-97.91%
Cagr3y	-82.01%
Cagr5y	-74.49%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	-21.13x
Revenue Growth Q	-51.35x
Revenue Growth Qo Q	-55x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-36.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$2.9M
Cash	$1.3M
Current Assets	$2.4M
Current Liabilities	$1.4M
Debt	$238,169
Debt FCF	$-0.03
Equity	$-1.8M
Interest Coverage	-944.3
Liabilities	$4.7M
Long Term Assets	$517,715
Long Term Liabilities	$3.3M
Net Cash	$1M
Net Cash By Market Cap	$33.4
Net Cash Growth	-83.55%
Tangible Book Value	$-1.8M
Tangible Book Value Per Share	$-0.55
WACC	9.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.7
Net Working Capital	$-15,828
Quick ratio	0.9
Working Capital	$1M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-83.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-97.9%
200-day SMA	10.99
3Y total return	-99.42%
50-day SMA	5.35
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.89%
All Time High	422.4
All Time High Change	-99.94%
All Time High Date	2018-05-22
All Time Low	0.26
All Time Low Change	1.34%
All Time Low Date	2025-03-20
ATR	1.26
Beta	1.13
Ch YTD	-94.87
High	0.28
High52	22.2
High52 Date	2025-02-26
High52ch	-98.81%
Low	0.26
Low52	0.26
Low52 Date	2025-03-20
Low52ch	1.34%
Ma50ch	-95.05%
Price vs 200-day SMA	-97.59%
RSI	38.65
RSI Monthly	30.53
RSI Weekly	35.28
Sharpe ratio	0.07x
Sortino ratio	0.2
Total Return	-83.42%
Tr YTD	-94.87
Tr1m	-94.04%
Tr1w	-94.74%
Tr3m	-93.66%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,418,394%
Net Borrowing	-260,621.3
Shares Insiders	2.91%
Shares Institutions	0.7%
Shares Qo Q	98.74%
Shares Yo Y	83.42%
Short Ratio	0.13

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.9M
Adjusted OCF	-7,850,539
Average Volume	9,214.35x
Bv Per Share	-0.55
CAPEX	$-17,335
Ch1m	-94.04
Ch1w	-94.74
Ch1y	-97.9
Ch3m	-93.66
Ch3y	-99.42
Ch5y	-99.89
Ch6m	-95.66
Change	2.08%
Change From Open	-0.23
Close	0.26
Days Gap	2.32
Depreciation Amortization	143,231
Dollar Volume	1,613.5
Earnings Date	2026-11-06
EBIT	$-8.5M
EBITDA	$-8.4M
EPS	$-2.84
F Score	2
FCF	$-7.6M
FCF EV Yield	-371.43x
Financing CF	1,992,783
Fiscal Year End	March
Founded	2,007
Income Tax	$3,769
Investing CF	53,513
Is Primary Listing	0
Last Earnings Date	2026-02-06
Last Report Date	2026-06-30
Last Split Date	2020-08-19
Last Split Type	Reverse
Ma150	8.46
Ma150ch	-96.87%
Ma20	6.32
Ma20ch	-95.81%
Net CF	-5,566,075
Next Earnings Date	2026-11-06
Open	0.27
Position In Range	18.42
Ppne	351,432.7
Price Date	2025-03-20
Relative Volume	0.66x
Revenue	84,414x
SBC By Revenue	282.14x
Share Based Comp	238,169
Tax By Revenue	4.46x
Tr6m	-95.66%
Volume	6,100
Z Score	-138.8

LON/0R02 (LON/0R02)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R02

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R02 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0R02

Frequently asked questions